Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Alliqua, Inc. (the "Company") is announcing a strategic realignment of the senior executive team. On January 30, 2013, the Alliqua Board of Directors elected David Johnson, who joined the Board in December, 2012 and is currently the executive chairman of AquaMed Technologies, Inc., a wholly-owned subsidiary of the Company, to the position of chief executive officer of Alliqua, Inc.

Concurrently, James Sapirstein, who had been the chief executive officer of Alliqua, Inc., will become the chief executive officer of Alliqua BioMedical Inc., the Company's wholly-owned subsidiary focused on introducing new active pharmaceutical ingredients into its hydrogel technology for the topical delivery of local and systemic therapies.

---